Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06823583
Recruiting
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Not applicable · United States · 2 sites
Registry update: 19 Sept 2025
NCT07116096
Recruiting
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
Not applicable · China · 2 sites
Registry update: 15 Sept 2026
NCT07671261
Recruiting
SEEG-Guided DBS for Schizophrenia
Not applicable · China · 1 site
Registry update: 26 Jun 2026
NCT06964464
Recruiting
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
Phase 4 · United States · 13 sites
Registry update: 18 Sept 2025
NCT07112339
Recruiting
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
Phase 4 · Canada, Germany, Italy · 75 sites
Registry update: 11 Aug 2026
NCT06931626
Recruiting
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
Phase 1 · United States · 3 sites
Registry update: 24 Jul 2026
NCT07118683
Recruiting
BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
Not applicable · Brazil · 9 sites
Registry update: 22 May 2026
NCT07026318
Recruiting
Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke
Not applicable · China · 1 site
Registry update: 22 Sept 2025
NCT07021274
Recruiting
DBT Skill Training for Autistic Adults With Difficulties in Emotion Regulation.
Not applicable · Norway · 1 site
Registry update: 13 Oct 2026
NCT07059013
Recruiting
A Chatbot-based Program to Promote Well-being in Caregivers of Children With Autism Spectrum Disorder
Not applicable · Hong Kong · 1 site
Registry update: 17 Dec 2025
NCT07278544
Recruiting
Harnessing Communication Preferences
Not applicable · United States · 2 sites
Registry update: 12 Dec 2025
NCT07130240
Recruiting
Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer
Phase 2 · China · 1 site
Registry update: 19 Aug 2025
NCT07260071
Recruiting
Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
Not applicable · United Kingdom · 1 site
Registry update: 4 Nov 2026
NCT06619405
Recruiting
AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
Not applicable · United States · 1 site
Registry update: 10 Aug 2026
NCT07073781
Recruiting
Probiotics, Cognition and Metabolic Health in Young Adults With Overweight or Obesity
Not applicable · United Kingdom · 1 site
Registry update: 9 Nov 2026
NCT07100405
Recruiting
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
Not applicable · China · 1 site
Registry update: 17 Aug 2025
NCT07125755
Recruiting
Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma
Phase 3 · China · 6 sites
Registry update: 23 Mar 2026
NCT06887192
Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2 · Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, Italy, South Korea, Poland, Portugal, Romania, Serbia, Slovakia, United States · 73 sites
Registry update: 30 Sept 2026
NCT06484062
Recruiting
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Phase 1 · United States · 23 sites
Registry update: 3 Nov 2026
NCT06996249
Recruiting
Prospective Data Collection Initiative on Thoracic Malignancies
Not applicable · Netherlands · 23 sites
Registry update: 7 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.